Back to top

Is ABIOMED (ABMD) Stock Outpacing Its Medical Peers This Year?

Read MoreHide Full Article

For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Has ABIOMED (ABMD - Free Report) been one of those stocks this year? Let's take a closer look at the stock's year-to-date performance to find out.

ABIOMED is a member of the Medical sector. This group includes 763 individual stocks and currently holds a Zacks Sector Rank of #12. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.

The Zacks Rank is a proven system that emphasizes earnings estimates and estimate revisions, highlighting a variety of stocks that are displaying the right characteristics to beat the market over the next one to three months. ABMD is currently sporting a Zacks Rank of #1 (Strong Buy).

Over the past three months, the Zacks Consensus Estimate for ABMD's full-year earnings has moved 6.65% higher. This signals that analyst sentiment is improving and the stock's earnings outlook is more positive.

Our latest available data shows that ABMD has returned about 118.65% since the start of the calendar year. Meanwhile, the Medical sector has returned an average of 1.45% on a year-to-date basis. This means that ABIOMED is outperforming the sector as a whole this year.

Looking more specifically, ABMD belongs to the Medical - Instruments industry, a group that includes 88 individual stocks and currently sits at #101 in the Zacks Industry Rank. On average, stocks in this group have lost 3.41% this year, meaning that ABMD is performing better in terms of year-to-date returns.

Investors in the Medical sector will want to keep a close eye on ABMD as it attempts to continue its solid performance.




In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


ABIOMED, Inc. (ABMD) - free report >>


More from Zacks Tale of the Tape

You May Like